GPB Scientific, Inc., a developer of breakthrough technologies for therapeutic cell production and bioprocessing, today announced a $25.5 million funding commitment. The financing is led by Vensana Capital alongside strategic investor Amgen Ventures with ongoing participation by existing investors…
Read the full article.
